Hematopoietic stem cell transplantation (HSCT) is a vital treatment for both malignant and non-malignant disorders in pediatric patients.

With the addition of Casgevy, Children’s Hospital Los Angeles now offers two gene therapies for sickle cell, the first being Lyfgenia.

Treatment for sickle cell disease, the most common inherited blood disorder in Kenya, has been approved for use in England for older children and adults with a severe form of the disease.The treatment ...

In this article, we explore the experiences of sickle cell patients in emergency care and the ways they can advocate for themselves ...

Exagamglogene autotemcel (exa-cel) gene therapy offers a potential cure for severe sickle cell disease, now available on NHS.

Accurate pain reporting in sickle cell disease is critical to effective pain assessment and management, but accuracy depends on patient comprehension of forms.

Our fundamental challenge is not simply to create the data. Rather, it is to collect and analyze it systematically. Doing so ...

Sickle cell anaemia is a genetic blood disorder characterised by the production of an abnormal haemoglobin, known as haemoglobin S. Sickle cell disease changes the shape of blood cells into a crescent ...

Hoosiers from across the state were at the State House for Sickle Cell Advocacy Day to shine a light on the financial burdens and medical coverage needs of those living with sickle cell disease.

Members of the Indiana General Assembly are urged to address the challenges faced by people with sickle cell disease, highlighting the need for expanded medical coverage.

A new gene editing treatment has been approved for use in the NHS, which will help treat sickle cell disease patients ...

Sickle cell disease (SCD) advocates are calling for Medicaid expansion before a rally at the statehouse on Monday.